Michael Ciesielski

Chief Executive Officer at MimiVax - Buffalo, NY, US

Michael Ciesielski's Colleagues at MimiVax

Michael Ciesielski's Contact Details

Email (Verified)
***@mimivax.com

Get Michael Ciesielski's Email Address

Mobile Number
(XXX) XXX-XXXX

Get Michael Ciesielski's Mobile Number

HQ
716-845-8850

Location
Buffalo-Niagara Falls Area

Company
MimiVax

Michael Ciesielski's Company Details

MimiVax

Buffalo, NY, US • 5 - 9 Employees
Major Drugs

Our vision, to disrupt cancer with the development of highly innovative immunotherapies aimed at increasing patient survival ratesMimiVax is a privately held, clinical-stage biotechnology company focused on the development and commercialization of immunotherapeutic vaccines and targeted therapies for the treatment of cancer. SurVaxM, our lead immunotherapeutic vaccine, has completed a Phase 2 clinical trial in adults with newly diagnosed glioblastoma. Additional indications are being evaluated through Phase 1 clinical trials in multiple myeloma combination with REVLIMID® (lenalidomide) as well as Phase 1 in Neuro-Endocrine Tumors (NET)

Immunotherapy Vaccines Oncology Pharmaceutical Developement B2B Major Drugs Pharmaceutical Preparations Pharmaceuticals

Details about MimiVax

Frequently Asked Questions about Michael Ciesielski

Michael Ciesielski currently works for MimiVax.

Michael Ciesielski's role at MimiVax is Chief Executive Officer.

Michael Ciesielski's email address is ***@mimivax.com. To view Michael Ciesielski's full email address, please signup to ConnectPlex.

Michael Ciesielski works in the Major Drugs industry.

Michael Ciesielski's colleagues at MimiVax are and others.

Michael Ciesielski's phone number is 716-845-8850